ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Treatment Strategies with ICIs (Efficacy and Safety Data for SC Products)"
Episode Synopsis
Atezolizumab and nivolumab are both FDA approved as SC products (pembrolizumab pending approval)Overall safety and efficacy of SC ICI products are similar to IV ICI counterpart therapiesPatients receiving SC ICI may experience mild injection site reactionsClinical guidelines (NCCN) recommend
More episodes of the podcast Conversations With Cancer Experts About Novel Delivery Options With Checkpoint Inhibitors (ICIs)
Summary of Key Concepts
31/07/2025
Background of ICI & Highlights in Oncology
30/07/2025
In God we trust